Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Peginterferon alfa-2a 180micrograms/mL injection 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
|
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
|
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Peginterferon alfa-2a-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 180 microgram/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 180 microgram/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 135 microgram/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 135 microgram/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing only peginterferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing only peginterferon alfa-2a in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 360 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 360 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |
Interferon alfa-2a (as peginterferon alfa-2a) 180 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2a |
Inferred relationship |
Some |
1 |